350396 <common-name>3-[2-[2-acetyl-3-(2-fluorophenyl)-3,4-dihydropyrazol-5-yl]phenyl]-5-methyl-2-(2-methyl-1h-indol-3-yl)-1,3-thiazolidin-4-one</common-name> <description>3-[2-[2-acetyl-3-(2-fluorophenyl)-3,4-dihydropyrazol-5-yl]phenyl]-5-methyl-2-(2-methyl-1h-indol-3-yl)-1,3-thiazolidin-4-one is a chemical compound with the formula C30H27FN4O2S. With an average molecular weight of 526.60 g/mol, 3-[2-[2-acetyl-3-(2-fluorophenyl)-3,4-dihydropyrazol-5-yl]phenyl]-5-methyl-2-(2-methyl-1h-indol-3-yl)-1,3-thiazolidin-4-one is a heavy molecule.</description> <cas>133405-37-5</cas> <pubchem-id>3077083</pubchem-id> <chemical-formula>C30H27FN4O2S</chemical-formula> <weight>526.6</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T15:26:42Z</created-at> <updated-at type="dateTime">2026-08-31T15:26:42Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC1C(=O)N(C(S1)C2=C(NC3=CC=CC=C32)C)C4=CC=CC=C4C5=NN(C(C5)C6=CC=CC=C6F)C(=O)C</moldb-smiles> <moldb-formula>C30H27FN4O2S</moldb-formula> <moldb-inchi>InChI=1S/C30H27FN4O2S/c1-17-28(22-12-5-8-14-24(22)32-17)30-34(29(37)18(2)38-30)26-15-9-6-11-21(26)25-16-27(35(33-25)19(3)36)20-10-4-7-13-23(20)31/h4-15,18,27,30,32H,16H2,1-3H3</moldb-inchi> <moldb-inchikey>HJHVSNSLMUWJAR-UHFFFAOYSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">526.1838755</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>5.2</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM346289</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>3-[2-[2-acetyl-3-(2-fluorophenyl)-3,4-dihydropyrazol-5-yl]phenyl]-5-methyl-2-(2-methyl-1h-indol-3-yl)-1,3-thiazolidin-4-one</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Indoles and derivatives</klass> <subklass>Indoles</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0300701</sync-id> <structure-inchikey>HJHVSNSLMUWJAR-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>600000000000000000000080000010400000000000000000000000001000000000020000000002080000000800010200000000000000000000000000000000000000008000000000000000000000000002000001000081000000000010000000000000001000000000000008000000080000002014000000000008104000050108000004000000080000020000000000000000000010000000000000040000000011804800000000004000008000000000000000000008000002000000000000000000004000000000020000001800000000000000000200020c200000001000000001000008000000060200020000420800000400000000000000800040000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAmAAAAKwAAAIABBgBgAAAAAQMGAGAAAAAD AQYAKAAAAAMECAAoAAAAAwIHACgAAAADAwYAYAAAAAMBEAAgAAAAAgZAKAAA AAMEBkAoAAAAAwQHQDgAAAADAQMGQCgAAAADBAZAaAAAAAMDAQZAaAAAAAMD AQZAaAAAAAMDAQZAaAAAAAMDAQZAKAAAAAMEBgBgAAAAAQMGQCgAAAADBAZA aAAAAAMDAQZAaAAAAAMDAQZAaAAAAAMDAQZAaAAAAAMDAQZAKAAAAAMEBgAo AAAAAwQHACgAAAADAwcAKAAAAAMDBgBgAAAAAwEGAGAAAAACAgZAKAAAAAME BkBoAAAAAwMBBkBoAAAAAwMBBkBoAAAAAwMBBkBoAAAAAwMBBkAoAAAAAwQJ ACAAAAABBgAoAAAAAwQIACgAAAADAgYAYAAAAAEDCwABAAECAAIDKAICBCAE BQAFBgAFBwAHCGgMCAloDAkKaAwKC2gMCwxoDAwNaAwNDmgMDg9oDAgQAAQR IBESaAwSE2gMExRoDBQVaAwVFmgMFhcgFxgoAhgZIBkaABobABocABwdaAwd HmgMHh9oDB8gaAwgIWgMISIAGSMgIyQoAiMlAAYBAA8HaAwPCmgMFhFoDBsX ACEcaAxCBgAAAAUBAgQFBgUIBw8KCQYLDA0ODwoGEhMUFRYRBRgXGxoZBh0e HyAhHBcEAAAAAAAAABY= </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:48:22Z</structure-indexed-at> </compound>